Across eight RCTs that provided data on numbers of patients with HF hospitalisation, there were 392/1328 patients (29.5%) who had at least one hospitalisation for HF in the BNP-guided therapy group, compared with 452/1327 patients (34%) in the symptom-guided therapy group. This evidence concerns the gene NPPB and hydrops fetalis.